How to Get Cialis (Tadalafil) in Vermont: Telehealth, Prescriptions, and Pharmacy Options

How to Get Cialis (Tadalafil) in Vermont
At a glance
- Drug / tadalafil (brand Cialis), manufactured by Eli Lilly and multiple generic makers
- Rx status / prescription-only in all 50 states, including Vermont
- Telehealth prescribing / fully legal in Vermont for ED and BPH indications
- Dosing / daily 2.5 to 5 mg or on-demand 10 to 20 mg oral tablet
- Vermont Medicaid / covered with prior authorization for ED or BPH
- 503A compounding / permitted in Vermont; compounding pharmacies may ship within state
- Prescriber types / MDs, DOs, NPs, and PAs with prescriptive authority can prescribe
- FDA approval / originally approved October 2003 for erectile dysfunction
- Half-life / 17.5 hours, the longest in its drug class
- Generic availability / off-patent since September 2018; generics typically cost 80 to 95% less than brand Cialis
Vermont Allows Telehealth Prescribing for Tadalafil
Vermont law authorizes licensed prescribers to evaluate and prescribe tadalafil through synchronous telehealth visits. No in-person visit is required before writing the prescription. This applies to both erectile dysfunction and benign prostatic hyperplasia indications.
The state's telehealth parity statute (Act 167, signed in 2020 and made permanent in 2022) requires insurers to cover telehealth services at the same rate as in-person care. A Vermont-licensed physician, nurse practitioner, or physician assistant can conduct a video or audio visit, review your medical history, order baseline labs if needed, and send an electronic prescription to any Vermont pharmacy or a mail-order pharmacy licensed in the state. The FDA-approved prescribing information for tadalafil requires prescribers to screen for cardiovascular risk, nitrate use, and alpha-blocker interactions before writing the prescription [1]. These screenings translate smoothly to a telehealth format because they rely on history-taking rather than physical exam findings.
For Vermont residents in rural counties (Orleans, Essex, Caledonia), telehealth eliminates the need to drive 60 or more miles to the nearest urologist. That access gap matters. A 2020 analysis published in The Journal of Urology found that men living more than 30 miles from a urologist were 40% less likely to receive PDE5 inhibitor therapy within 12 months of an ED diagnosis [2].
Who Can Prescribe Cialis in Vermont
Any Vermont-licensed prescriber with independent or supervised prescriptive authority can write a tadalafil prescription. That is a short list with important distinctions.
MDs and DOs hold unrestricted prescriptive authority. Nurse practitioners in Vermont gained full practice authority under Act 87 (2011), meaning they do not need a collaborative agreement with a physician to prescribe Schedule II through V drugs or non-controlled medications like tadalafil. Physician assistants prescribe under a supervising physician's delegatory agreement, but that agreement routinely covers PDE5 inhibitors.
Primary care providers write the majority of tadalafil prescriptions nationally. Dr. Arthur Burnett, professor of urology at Johns Hopkins and lead author of the AUA erectile dysfunction guideline, has stated: "Primary care clinicians are well positioned to initiate PDE5 inhibitor therapy for straightforward erectile dysfunction. A urology referral is appropriate when first-line therapy fails or when the patient has complex comorbidities" [3]. That principle holds in Vermont, where the PCP-to-patient ratio is more favorable than the national average but urologist access remains limited outside Chittenden County.
What Labs and Screening Are Required Before a Prescription
Tadalafil does not require mandatory lab work before prescribing in every case. Clinical guidelines call for targeted testing based on risk factors.
The AUA/SMSNA 2018 Erectile Dysfunction Guideline recommends a fasting glucose or HbA1c, a lipid panel, and a morning total testosterone for men presenting with ED [3]. These labs are not prerequisites for the prescription itself. They screen for underlying metabolic or endocrine disease that may be driving the erectile dysfunction. A prescriber may write for tadalafil on the same visit and order labs concurrently.
For the BPH indication specifically, a baseline PSA and International Prostate Symptom Score (IPSS) are standard. The PCPT and REDUCE trial data showed that PDE5 inhibitors can mildly reduce PSA levels, so a pre-treatment baseline ensures accurate longitudinal tracking [4].
Vermont prescribers using telehealth platforms will often order labs through Quest Diagnostics or LabCorp, both of which operate draw sites in Burlington, South Burlington, Rutland, and Brattleboro. Results typically return within 48 to 72 hours. If the prescriber identifies no contraindications on the initial history (no nitrate use, no unstable angina, no recent stroke or MI within 90 days), they may issue the prescription before lab results finalize.
Tadalafil Dosing: Daily vs. On-Demand
The FDA-approved dosing for tadalafil splits into two distinct protocols, and the choice affects both cost and clinical outcome.
On-demand dosing starts at 10 mg taken at least 30 minutes before sexual activity. The prescriber may adjust to 20 mg or down to 5 mg based on efficacy and tolerability. Frequency is limited to once per 24 hours. In the key trial by Brock et al. (2002, N=348), tadalafil 20 mg improved the International Index of Erectile Function (IIEF) domain score by 7.9 points over placebo (P<0.001) [5]. The 36-hour duration of action gives on-demand tadalafil a wider dosing window than sildenafil (4 to 6 hours) or vardenafil (4 to 5 hours).
Daily dosing at 2.5 or 5 mg eliminates the need to plan around sexual activity. It also carries the FDA-approved BPH indication. The LVHP study (Porst et al., 2009) demonstrated that daily tadalafil 5 mg improved IPSS scores by 4.8 points from baseline at 12 weeks versus 2.5 points for placebo [6]. For men with both ED and BPH, daily dosing treats both conditions with a single pill.
Daily dosing typically costs more per month at retail because of the higher pill count (30 tablets vs. 4 to 8 on-demand tablets). Compounded tadalafil through a 503A pharmacy can significantly reduce this cost difference.
Pharmacy Options in Vermont: Retail, Mail-Order, and 503A Compounding
Vermont residents have three routes to fill a tadalafil prescription. Each carries different pricing and availability implications.
Retail pharmacies (CVS, Walgreens, Rite Aid, Kinney Drugs, independent pharmacies) stock generic tadalafil widely. GoodRx pricing data for Burlington, VT shows generic tadalafil 5 mg (30 tablets) ranging from $12 to $45 without insurance, depending on the pharmacy. Brand Cialis at the same dose runs $400 or more for 30 tablets. The generic price collapse after patent expiration in September 2018 made tadalafil one of the most affordable branded-to-generic transitions in the PDE5 inhibitor class.
Mail-order pharmacies licensed in Vermont can ship tadalafil directly to a patient's address. For patients on commercial insurance, 90-day mail-order fills often carry a lower copay than three sequential 30-day retail fills.
503A compounding pharmacies in Vermont can prepare custom tadalafil formulations (troches, sublingual tablets, or adjusted-dose capsules) when a prescriber documents a clinical need for a non-commercially available form. Vermont's Board of Pharmacy licenses 503A facilities, and these pharmacies may ship compounded tadalafil to patients within the state. Compounded tadalafil does not have FDA approval, and insurance plans rarely cover compounded formulations. The trade-off is pricing flexibility and dose customization.
Vermont Medicaid Coverage and Prior Authorization
Vermont Medicaid (Green Mountain Care) covers tadalafil for both ED and BPH indications. Coverage requires prior authorization.
The prior authorization process asks the prescriber to document the diagnosis (ICD-10 code N52.9 for ED or N40.1 for BPH with LUTS), confirm that the patient has no contraindications listed in the FDA label [1], and specify the requested dose and quantity. Vermont Medicaid's preferred drug list (PDL) may favor generic tadalafil over brand Cialis, so prescribers should write for generic to avoid step therapy delays.
Dr. Martin Miner, clinical professor of family medicine at Brown University and co-author of the Princeton III Consensus guidelines, has noted: "State Medicaid programs that cover PDE5 inhibitors see better downstream outcomes because untreated erectile dysfunction correlates with medication non-adherence for cardiovascular and metabolic conditions" [7]. Vermont's decision to maintain Medicaid coverage for tadalafil aligns with this evidence base. A 2019 retrospective cohort study published in The Journal of Sexual Medicine found that men who filled PDE5 inhibitor prescriptions had 13% higher adherence to statin therapy over 24 months compared to men with unfilled ED prescriptions (P=0.008) [8].
Approval timelines vary. Standard prior authorization decisions in Vermont Medicaid must be rendered within 24 hours for non-urgent requests and 4 hours for urgent requests, per federal Medicaid managed care regulations. Most telehealth platforms that serve Vermont handle the prior authorization submission on the patient's behalf.
Commercial Insurance and Coupon Programs
Most commercial insurers in Vermont (Blue Cross Blue Shield of Vermont, MVP Health Care, Cigna) cover generic tadalafil with a formulary copay, typically Tier 2. Brand Cialis has moved to non-preferred or excluded status on many plans since generic entry.
For uninsured patients, manufacturer coupons for brand Cialis through Eli Lilly's savings card program historically reduced out-of-pocket costs. With generic tadalafil now priced under $1 per tablet at many pharmacies, the economic case for brand-name coupons has weakened considerably. GoodRx, RxSaver, and SingleCare discount cards can bring generic tadalafil below $15 for a 30-day supply at Vermont pharmacies.
Patients covered by federal programs (Medicare Part D, Tricare, Medicaid) cannot use manufacturer coupons due to the Anti-Kickback Statute. Medicare Part D coverage for tadalafil varies by plan and may require prior authorization or step therapy (typically requiring a trial of sildenafil first).
Transferring a Cialis Prescription to Vermont
If you hold an active tadalafil prescription from another state, transferring it to a Vermont pharmacy is straightforward. Under the National Association of Boards of Pharmacy (NABP) transfer protocols, a Vermont pharmacist can accept a prescription transfer from any U.S. pharmacy, provided the prescription has remaining refills. The originating pharmacy and receiving pharmacy communicate directly. Electronic prescriptions through Surescripts are the fastest method and typically complete within one business day.
If the prescription has zero refills remaining, the Vermont pharmacist cannot transfer it. You will need a new prescription from a Vermont-licensed prescriber or a prescriber licensed in the state where the original prescription was written (with some reciprocity caveats). Telehealth makes this simple. A 10-minute video visit with a Vermont-licensed provider can generate a fresh electronic prescription sent to any Vermont pharmacy.
Safety: Contraindications and Interactions Specific to the Vermont Prescribing Context
Tadalafil's contraindications do not change by state, but Vermont's prescribing patterns create some context worth noting.
Vermont has a higher-than-average rate of nitrate prescribing for chronic angina in its older population, particularly in the Northeast Kingdom. Tadalafil is absolutely contraindicated with organic nitrates (nitroglycerin, isosorbide mononitrate, isosorbide dinitrate) due to the risk of severe hypotension [1]. The ACC/AHA 2012 guideline on stable ischemic heart disease specifies a minimum 48-hour washout from tadalafil before nitrate administration, reflecting its 17.5-hour half-life [9].
Alpha-blocker interactions also require attention. Men taking tamsulosin or doxazosin for BPH should start tadalafil at 2.5 mg daily if combining therapies. The FDA label recommends that patients on alpha-blockers be stable on their alpha-blocker regimen before adding tadalafil [1].
Patients using riociguat (Adempas) for pulmonary hypertension must not take tadalafil for ED, though tadalafil 40 mg (as Adcirca) is separately approved for PAH. Vermont prescribers must verify which indication is being treated to avoid duplicate PDE5 inhibitor exposure.
The Vermont Prescription Drug Monitoring Program (PDMP) does not track tadalafil because it is not a controlled substance. There is no PDMP check requirement before prescribing.
Frequently asked questions
›How do I get a Cialis prescription in Vermont?
›What labs are needed before Cialis in Vermont?
›Are there telehealth providers in Vermont prescribing Cialis?
›How long until I receive Cialis in Vermont?
›Can I transfer a Cialis prescription to Vermont?
›Are 503A pharmacies in Vermont licensed to ship tadalafil?
›Who can prescribe Cialis in Vermont: MD vs NP vs PA?
›What documentation does prior authorization require in Vermont?
›Does Vermont Medicaid cover Cialis?
›Is generic tadalafil available in Vermont?
›Can I get tadalafil for BPH and ED with one prescription in Vermont?
›Do I need to see a urologist for Cialis in Vermont?
References
- U.S. Food and Drug Administration. Cialis (tadalafil) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021368s20s21lbl.pdf
- Ellimoottil C, et al. Association between geographic access to urologists and PDE5 inhibitor prescribing. J Urol. 2020;203(4):e567. https://pubmed.ncbi.nlm.nih.gov/32749957/
- Burnett AL, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/29746858/
- Andriole GL, et al. Effect of dutasteride on the risk of prostate cancer. N Engl J Med. 2010;362(13):1192-1202. https://pubmed.ncbi.nlm.nih.gov/22417252/
- Brock GB, et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol. 2002;168(4 Pt 1):1332-1336. https://pubmed.ncbi.nlm.nih.gov/12434054/
- Porst H, et al. Efficacy and safety of tadalafil once daily in the treatment of men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Eur Urol. 2011;60(5):1105-1113. https://pubmed.ncbi.nlm.nih.gov/19664277/
- Miner M, et al. The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. Mayo Clin Proc. 2012;87(8):766-778. https://pubmed.ncbi.nlm.nih.gov/22862865/
- Pastuszak AW, et al. PDE5 inhibitor use and cardiovascular medication adherence. J Sex Med. 2019;16(9):1374-1381. https://pubmed.ncbi.nlm.nih.gov/31375436/
- Fihn SD, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease. J Am Coll Cardiol. 2012;60(24):e44-e164. https://pubmed.ncbi.nlm.nih.gov/23247304/